Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

Clinical trial NCT07610343 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07610343
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Older Adults Cognitive Impairment Sleep Disorders Dexmedetomidine Esketamine

Start date: 2026-06-01
Primary completion: 2027-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.